Vecilmeran

Approval Year

Name

Type

Language

Vecilmeran

Official Name

English

vecilmeran [INN]

Common Name

English

RNA (recombinant 5′-(m7G-(5′→5′)-ppp-Gm)-capped human immunoglobulin IgE ε-chain signal peptide plus severe acute respiratory syndrome coronavirus 2 spike glycoprotein B.1.1.529.4 and B.1.1.529.5 variant receptor-binding domain plus 5′-and

Common Name

English

messenger RNA (mRNA), 5'-capped, encoding a codon-optimised receptor binding domain (RBD) of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) glycoprotein (Omicron sub-lineages B.1.1.529.4 and B.1.1.529.5; also known as BA.4 and

Common Name

English

Code System Code Type Description

FDA UNII

28PLX9696B

Created by admin on Sat Dec 16 20:17:03 GMT 2023 , Edited by admin on Sat Dec 16 20:17:03 GMT 2023

PRIMARY

CAS

2854349-87-2

Created by admin on Sat Dec 16 20:17:03 GMT 2023 , Edited by admin on Sat Dec 16 20:17:03 GMT 2023

PRIMARY

INN

12895

Created by admin on Sat Dec 16 20:17:03 GMT 2023 , Edited by admin on Sat Dec 16 20:17:03 GMT 2023

PRIMARY

Sugar	Site Range	Site Count
D-Ribose (RNA)	1_1-1_1042	1042 / 1042

Linkage	Site Range	Site Count
Phosphate	1_2-1_1042	1041 / 1041

ACTIVE MOIETY


					28PLX9696B

Vecilmeran